Malignant Tumors Clinical Trials in Nanjing, Jiangsu
2 recruitingNanjing, Jiangsu, China
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Clinical Trial Evaluating Injection of TQB6411 in Subjects With Advanced Malignant Tumors
Advanced Malignant Tumors
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.216 enrolled19 locationsNCT07043751
Recruiting
Phase 2
Donafenib Combined With Capecitabine for Postoperative Adjuvant Therapy of Biliary Malignant Tumors With High-risk Recurrence Risk
Biliary Malignant Tumors
The First Affiliated Hospital with Nanjing Medical University70 enrolled1 locationNCT06685289